Intelligent Investing News
Intelligent Investing News
|
Lightning Round: Air Products, McDonald's, ATP Gas & Oil (at CNBC)
|
|
|
'Mad Money Lightning Round': Go With Green Mountain Coffee Roasters (at TheStreet.com)
|
|
|
Cramer's 'Mad Money' Recap: Next Week's Game Plan (Final) (at TheStreet.com)
|
|
|
UPDATE - FDA issues warning for high doses of Zocor (at Reuters)
|
|
|
US warns of greater muscle risk from Zocor (AP)
|
The Food and Drug Administration said Friday the highest available dose of Zocor, a component in cholesterol drugs, can cause muscle damage as well as severe and potentially lethal kidney damage.
|
|
The Abbott Fund, Boston University School of Medicine and Leading Health Institutions in Vietnam Inaugurate the Abbott Fund Institute of Nutrition Science at Bach Mai Hospital (PR Newswire)
|
The Abbott Fund, the philanthropic arm of the global health care company Abbott , and the Global Health Primary Care Initiative at the Boston University School of Medicine joined Bach Mai Hospital, the National Institute of Nutrition and Hanoi Medical University today to announce the opening of the Abbott Fund Institute of Nutrition Science . AFINS is the first program of its kind in Vietnam to advance clinical nutrition within hospitals by providing training and health education, clinical research and high-quality nutritional patient care nationwide.
|
|
Abbott Labs: Dividend Stock Analysis (at Seeking Alpha)
|
|
|
Is Socialized Medicine Bad for Your Wealth? (at The Wall Street Journal Online)
|
|
|
Boston Sci Dips; More FDA Trouble? (at Barrons.com)
|
|
|
How Ordinary Investors Trounced the Lost Decade (at Motley Fool)
|
|
|
UPDATE - Breast cancer study aims to speed drugs, cooperation (at Reuters)
|
|
|
The Promise Behind Incyte (at Minyanville.com)
|
Analysts are bullish on a new drug study for a large market.
|
|
Five Funds for Dividend Hunters (at Minyanville.com)
|
|
|
Goldman's 10 Favorite High Yield Growth Plays (at Seeking Alpha)
|
|
|
MannKind Falls 3.8%; Is the Worst Over? (at Barrons.com)
|
|
|
UPDATE - Long-term safety of drug-coated stents questioned (at Reuters)
|
|
|
Drugs Are For Sick People (at Forbes.com)
|
|
|
UPDATE - Axis-Shield FY pretax profit up, sees maiden div in '10 (at Reuters)
|
|
|
Abbott CEO's pay falls on reduced stock options (AP)
|
The chairman and CEO at Abbott Laboratories received a 13 percent drop in total compensation last year, mainly as a result of reduced stock options.
|
|
Before Tuesday's Fed Report, Key Data Is Light (at Investor's Business Daily, Inc.)
|
|
Intelligent Investing News
Intelligent Investing News
